UM-164: A Potent c-Src/p38 Kinase Inhibitor with In Vivo Activity against Triple-Negative Breast Cancer

Type: Retraction
Notice date: 4/1/2020 0:00
Journal: Clinical Cancer Research: An Official Journal of the American Association for Cancer Research
Publisher: American Association for Cancer Research
Notice DOI: 10.1158/1078-0432.ccr-20-0653
Original paper DOI: 10.1158/1078-0432.ccr-15-2158

Reasons